CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 198, Issue 11, Pages 4490-4501
Publisher
The American Association of Immunologists
Online
2017-04-29
DOI
10.4049/jimmunol.1601988
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autoantibodies, citrullinated histones and initiation of synovitis
- (2015) Kevin D. Deane Nature Reviews Rheumatology
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes
- (2014) Katherine A. Gallagher et al. DIABETES
- Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases
- (2014) J. H. Xie et al. JOURNAL OF IMMUNOLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance
- (2013) M. Spencer et al. DIABETES
- Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis
- (2013) Lujun Chen et al. IMMUNOLOGY LETTERS
- Human Genetics in Rheumatoid Arthritis Guides a High-Throughput Drug Screen of the CD40 Signaling Pathway
- (2013) Gang Li et al. PLoS Genetics
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
- (2012) Laurens Kruidenier et al. NATURE
- Inflammation and Bone Destruction in Arthritis: Synergistic Activity of Immune and Mesenchymal Cells in Joints
- (2012) Noriko Komatsu et al. Frontiers in Immunology
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses
- (2011) Janin Hofmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma
- (2011) J A Anderton et al. ONCOGENE
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
- (2010) Da Young Oh et al. CELL
- Differential TRAF3 Utilization by a Variant Human CD40 Receptor with Enhanced Signaling
- (2010) A. L. Peters et al. JOURNAL OF IMMUNOLOGY
- The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
- (2010) Takashi Satoh et al. NATURE IMMUNOLOGY
- Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study
- (2009) G. Orozco et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of a single-nucleotide polymorphism inCD40with the rate of joint destruction in rheumatoid arthritis
- (2009) Michael P. M. van der Linden et al. ARTHRITIS AND RHEUMATISM
- Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
- (2009) Francesca De Santa et al. EMBO JOURNAL
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- Common variants at CD40 and other loci confer risk of rheumatoid arthritis
- (2008) Soumya Raychaudhuri et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started